Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trialThe Lancet (British edition), 2021-05, Vol.397 (10287), p.1809-1818 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00943-0 ;PMID: 33964223Full text available |
|
2 |
Material Type: Article
|
Viral gastroenteritisThe Lancet (British edition), 2018-07, Vol.392 (10142), p.175-186 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31128-0 ;PMID: 30025810Full text available |
|
3 |
Material Type: Article
|
Global health 2035: a world converging within a generationThe Lancet (British edition), 2013-12, Vol.382 (9908), p.1898-1955 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Dec 7, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62105-4 ;PMID: 24309475 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2014-06, Vol.383 (9935), p.2136-2143 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 21, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62630-6 ;PMID: 24629994 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
RTS,S malaria vaccine pilots in three African countriesThe Lancet (British edition), 2019-04, Vol.393 (10182), p.1685-1685 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30937-7 ;PMID: 31034365Full text available |
|
6 |
Material Type: Article
|
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine accessThe Lancet, 2020-09, Vol.396 (10254), p.800-802 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31873-0 ;PMID: 32910908Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Serotype replacement in disease after pneumococcal vaccinationThe Lancet (British edition), 2011-12, Vol.378 (9807), p.1962-1973 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3-Dec 9, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)62225-8 ;PMID: 21492929 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Article
|
Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?The Lancet (British edition), 2013-04, Vol.381 (9875), p.1417-1429 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 20, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60648-0 ;PMID: 23582723 ;CODEN: LANCAOFull text available |
|
9 |
Material Type: Article
|
Challenges ahead for the new head of GaviThe Lancet (British edition), 2024-01, Vol.403 (10423), p.234-234 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00092-8 ;PMID: 38246196Full text available |
|
10 |
Material Type: Article
|
What next for a COVID-19 intellectual property waiver?The Lancet (British edition), 2021-05, Vol.397 (10288), p.1871-1872 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01151-X ;PMID: 34022975Full text available |
|
11 |
Material Type: Article
|
DNA vaccines join the fight against COVID-19The Lancet (British edition), 2022-04, Vol.399 (10332), p.1281-1282 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00524-4 ;PMID: 35366995Full text available |
|
12 |
Material Type: Article
|
Decoupling of omicron variant infections and severe COVID-19The Lancet (British edition), 2022-03, Vol.399 (10329), p.1047-1048 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00109-X ;PMID: 35189080Full text available |
|
13 |
Material Type: Article
|
Viral pneumoniaThe Lancet (British edition), 2011-04, Vol.377 (9773), p.1264-1275 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 9-Apr 15, 2011 ;Copyright © 2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61459-6 ;PMID: 21435708 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
COV-BOOST: evidence to support rapid booster deploymentThe Lancet (British edition), 2021-12, Vol.398 (10318), p.2209-2211 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;Crown Copyright © 2022 Published by Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02799-9 ;PMID: 34922657Full text available |
|
15 |
Material Type: Article
|
The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recoveryThe Lancet (British edition), 2023-08, Vol.402 (10401), p.510-512 [Peer Reviewed Journal]2023 World Health Organization ;2023. World Health Organization ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01468-X ;PMID: 37478887Full text available |
|
16 |
Material Type: Article
|
Closing the global vaccine equity gap: equitably distributed manufacturingThe Lancet (British edition), 2022-05, Vol.399 (10339), p.1924-1926 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00793-0 ;PMID: 35533706Full text available |
|
17 |
Material Type: Article
|
Revitalising the right to health is essential to securing better health for allThe Lancet (British edition), 2024-04, Vol.403 (10434), p.1315-1318 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00582-8 ;PMID: 38522450Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Backsliding on human rights and equity in the Pandemic AccordThe Lancet (British edition), 2023-06, Vol.401 (10393), p.2019-2021 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01118-2 ;PMID: 37271154Full text available |
|
19 |
Material Type: Article
|
Vaccine shortages prompt changes to COVAX strategyThe Lancet (British edition), 2021-10, Vol.398 (10310), p.1474-1474 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02309-6 ;PMID: 34688360Full text available |
|
20 |
Material Type: Article
|
Calls for independent evaluation of ACT-A welcomedThe Lancet (British edition), 2022-05, Vol.399 (10340), p.2006-2006 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00974-6 ;PMID: 35644147Full text available |